Microarray analysis of bone marrow-derived macrophage cells treated with Kdo₂-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios KEGG pathway: Phagosome (mmu04145) Legend: : View data/graphs for replicates Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr 14927508 3 KLA  ATP  ATP+KLA 149275083 Unknown KLA .74 .68 .68 .77 .71 .85 .69 ATP .85 .69 1.26 .89 .89 1.26 .64 KLA/ATP .64 .63 1.07 .96 1.39 1.07 .82 5430435G 22Rik KLA  ATP  ATP+KLA NM_145509 RIKEN cDNA 5430435G22 gene (5430435G22Rik), mRNA [NM_145509] KLA .11 .11 .22 .41 .66 1.09 .87 ATP 1.02 .96 1.19 .84 .89 .58 1.60 KLA/ATP .11 .11 .23 .28 .87 .62 1.51 AK032538 KLA  ATP  ATP+KLA AK032538 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430586B05 product:unclassifiable, full insert sequence [AK032538] KLA .97 .99 .99 .93 .97 .98 .97 ATP .99 .95 .99 .94 .98 1.05 1.00 KLA/ATP .93 1.02 .98 .98 1.05 .88 1.05 Actb KLA  ATP  ATP+KLA BC016624 cDNA clone IMAGE:4501052 [BC016624] KLA 1.20 1.20 1.19 1.73 1.83 2.52 1.70 ATP 1.04 1.01 1.03 .92 1.07 .66 .91 KLA/ATP 1.34 1.40 1.69 1.28 1.27 1.19 1.06 Actb KLA  ATP  ATP+KLA NM_007393 actin, beta, cytoplasmic (Actb), mRNA [NM_007393] KLA 1.58 1.64 1.59 2.02 2.03 3.04 1.75 ATP 1.00 .95 1.26 1.18 1.33 .86 .91 KLA/ATP 1.52 1.75 2.42 1.92 2.17 1.54 1.28 Actg1 KLA  ATP  ATP+KLA NM_009609 actin, gamma, cytoplasmic 1 (Actg1), mRNA [NM_009609] KLA 1.02 1.03 1.34 1.07 1.49 1.58 .71 ATP 1.07 1.24 .76 .76 .63 .46 .78 KLA/ATP 1.20 1.30 .75 .82 .60 .53 .55 Atp6ap1 KLA  ATP  ATP+KLA NM_018794 ATPase, H+ transporting, lysosomal accessory protein 1 (Atp6ap1), mRNA [NM_018794] KLA .73 .83 .89 .71 .74 .71 1.06 ATP 1.05 1.08 .94 1.12 .99 .79 1.07 KLA/ATP .90 .81 .72 .84 .62 .64 .97 Atp6v0a1 KLA  ATP  ATP+KLA AK045877 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230316H04 product:unclassifiable, full insert sequence [AK045877] KLA .65 .64 .58 .48 .57 .46 .29 ATP .64 .28 .48 .28 .45 .30 .91 KLA/ATP .51 .26 .37 .31 .54 .45 .63 Atp6v0a1 KLA  ATP  ATP+KLA NM_016920 ATPase, H+ transporting, lysosomal V0 subunit A1 (Atp6v0a1), mRNA [NM_016920] KLA .88 .91 .88 .80 .66 .52 .45 ATP 1.05 1.22 .91 1.05 .58 .40 1.46 KLA/ATP .97 1.04 .80 .89 .55 .43 .75 Atp6v0a2 KLA  ATP  ATP+KLA AK160318 16 days embryo lung cDNA, RIKEN full-length enriched library, clone:8430408C20 product:unclassifiable, full insert sequence [AK160318] KLA 1.21 1.13 1.18 1.30 1.39 1.58 1.38 ATP 1.10 .94 .55 .35 .72 .96 .84 KLA/ATP 1.12 1.08 .82 .54 .81 1.05 .59 Atp6v0a2 KLA  ATP  ATP+KLA BC112905 ATPase, H+ transporting, lysosomal V0 subunit A2, mRNA (cDNA clone MGC:118073 IMAGE:3670722), complete cds [BC112905] KLA 1.65 1.66 1.74 2.07 1.97 2.78 2.71 ATP .88 .61 .53 .30 .38 1.26 2.12 KLA/ATP 1.38 1.29 .91 .62 .59 1.36 2.13 Atp6v0a2 KLA  ATP  ATP+KLA NM_011596 ATPase, H+ transporting, lysosomal V0 subunit A2 (Atp6v0a2), mRNA [NM_011596] KLA 2.26 2.07 2.01 2.71 2.48 3.69 2.76 ATP .79 .64 .62 .42 .62 2.31 3.11 KLA/ATP 1.69 1.57 1.47 .90 1.06 2.56 4.84 Atp6v0a4 KLA  ATP  ATP+KLA NM_080467 ATPase, H+ transporting, lysosomal V0 subunit A4 (Atp6v0a4), mRNA [NM_080467] KLA 1.01 1.00 .99 1.03 1.01 1.02 .98 ATP 1.02 1.05 .93 1.03 1.05 1.01 .97 KLA/ATP 1.02 .94 1.00 .99 1.00 1.01 1.03 Atp6v0b KLA  ATP  ATP+KLA NM_033617 ATPase, H+ transporting, lysosomal V0 subunit B (Atp6v0b), mRNA [NM_033617] KLA .91 1.00 1.07 .81 1.25 1.34 1.44 ATP 1.12 1.33 .80 1.41 1.47 1.67 1.77 KLA/ATP 1.20 1.16 .62 1.28 1.01 1.77 2.37 Atp6v0c KLA  ATP  ATP+KLA NM_009729 ATPase, H+ transporting, lysosomal V0 subunit C (Atp6v0c), mRNA [NM_009729] KLA .89 .98 1.05 .90 1.18 1.38 1.52 ATP 1.07 1.28 .93 1.66 1.48 1.35 2.35 KLA/ATP 1.10 1.12 .67 1.50 1.18 1.66 2.51 Atp6v0d1 KLA  ATP  ATP+KLA NM_013477 ATPase, H+ transporting, lysosomal V0 subunit D1 (Atp6v0d1), mRNA [NM_013477] KLA .84 .85 .94 .79 1.10 1.24 1.27 ATP 1.18 1.48 .94 1.40 1.12 .75 1.85 KLA/ATP 1.05 1.06 .59 1.06 .83 .85 1.96 Atp6v0d2 KLA  ATP  ATP+KLA NM_175406 ATPase, H+ transporting, lysosomal V0 subunit D2 (Atp6v0d2), mRNA [NM_175406] KLA .77 .72 .64 .54 .43 .27 .18 ATP 1.19 1.35 1.06 1.47 1.46 .79 .96 KLA/ATP .78 .95 .63 1.12 1.21 1.01 .50 Atp6v0e KLA  ATP  ATP+KLA AK134836 adult male medulla oblongata cDNA, RIKEN full-length enriched library, clone:6330589P19 product:ATPase, H+ transporting, V0 subunit, full insert sequence. [AK134836] KLA 1.09 1.06 1.02 1.42 1.32 1.14 .92 ATP .93 1.18 1.02 1.34 1.72 1.34 1.44 KLA/ATP .97 .89 .94 1.32 2.01 1.43 1.72 Atp6v0e KLA  ATP  ATP+KLA NM_025272 ATPase, H+ transporting, lysosomal V0 subunit E (Atp6v0e), mRNA [NM_025272] KLA 1.00 .95 .87 .99 .98 1.20 1.26 ATP .91 .98 1.11 1.17 1.29 1.54 1.59 KLA/ATP .86 .94 1.07 1.05 1.29 1.57 1.83 Atp6v0e2 KLA  ATP  ATP+KLA NM_133764 ATPase, H+ transporting, lysosomal V0 subunit E2 (Atp6v0e2), mRNA [NM_133764] KLA .98 .93 .90 .99 .88 .90 .92 ATP 1.08 1.02 1.03 1.07 .98 .88 .94 KLA/ATP .98 .99 .97 1.00 .89 .90 .88 Atp6v1a KLA  ATP  ATP+KLA NM_007508 ATPase, H+ transporting, lysosomal V1 subunit A (Atp6v1a), mRNA [NM_007508] KLA .77 .77 .70 .59 .58 .61 .84 ATP 1.04 1.45 .99 1.82 1.34 1.00 1.21 KLA/ATP .82 .97 .55 1.13 .73 .99 1.09 Atp6v1b1 KLA  ATP  ATP+KLA NM_134157 ATPase, H+ transporting, lysosomal V1 subunit B1 (Atp6v1b1), mRNA [NM_134157] KLA 1.00 1.03 1.11 .95 1.01 1.00 1.03 ATP 1.02 1.05 1.01 .97 1.02 .97 1.02 KLA/ATP .98 .94 1.03 1.02 .99 1.00 .96 Atp6v1b2 KLA  ATP  ATP+KLA NM_007509 ATPase, H+ transporting, lysosomal V1 subunit B2 (Atp6v1b2), mRNA [NM_007509] KLA .89 .98 1.11 1.07 1.24 1.13 1.12 ATP 1.05 1.11 1.02 1.09 1.03 .79 1.39 KLA/ATP .97 1.05 .95 1.12 1.12 1.37 1.67 Atp6v1c1 KLA  ATP  ATP+KLA NM_025494 ATPase, H+ transporting, lysosomal V1 subunit C1 (Atp6v1c1), mRNA [NM_025494] KLA .61 .62 .59 .51 .56 .71 .92 ATP .98 .97 .93 1.07 1.42 1.00 1.28 KLA/ATP .61 .57 .48 .57 1.04 1.18 1.18 Atp6v1c2 KLA  ATP  ATP+KLA NM_133699 ATPase, H+ transporting, lysosomal V1 subunit C2 (Atp6v1c2), mRNA [NM_133699] KLA 1.00 .93 .98 .97 1.04 .99 .97 ATP 1.07 .97 .99 .97 .97 1.04 1.06 KLA/ATP 1.01 1.03 1.00 1.03 1.00 .91 .97 Atp6v1d KLA  ATP  ATP+KLA NM_023721 ATPase, H+ transporting, lysosomal V1 subunit D (Atp6v1d), mRNA [NM_023721] KLA 1.45 1.39 1.73 1.95 1.83 2.08 1.29 ATP .91 .88 1.19 1.12 1.73 1.64 2.34 KLA/ATP 1.25 1.32 1.80 1.46 2.05 2.00 2.22 Atp6v1e1 KLA  ATP  ATP+KLA NM_007510 VATPase, H+ transporting, lysosomal V1 subunit E1 (Atp6v1e1), mRNA [NM_007510] KLA 1.48 1.55 1.79 1.73 1.79 1.59 1.37 ATP .88 .73 .59 .73 1.30 1.59 1.40 KLA/ATP 1.50 1.43 1.24 1.30 1.57 1.69 1.76 Atp6v1e2 KLA  ATP  ATP+KLA NM_029121 ATPase, H+ transporting, lysosomal V1 subunit E2 (Atp6v1e2), mRNA [NM_029121] KLA 1.01 1.04 1.11 1.14 1.19 1.15 1.11 ATP 1.00 .97 1.11 1.06 1.07 1.02 1.08 KLA/ATP 1.03 1.10 1.19 1.10 1.13 1.06 1.09 Atp6v1f KLA  ATP  ATP+KLA NM_025381 ATPase, H+ transporting, lysosomal V1 subunit F (Atp6v1f), mRNA [NM_025381] KLA .92 .94 .93 .96 .96 1.02 1.05 ATP .97 .96 1.07 1.18 1.31 1.16 1.11 KLA/ATP .92 .96 1.06 1.12 1.28 1.24 1.14 Atp6v1g1 KLA  ATP  ATP+KLA NM_024173 ATPase, H+ transporting, lysosomal V1 subunit G1 (Atp6v1g1), mRNA [NM_024173] KLA .97 .94 .87 .99 .98 1.01 .96 ATP 1.02 1.02 1.09 1.10 1.29 1.23 1.41 KLA/ATP .83 .92 1.12 1.10 1.23 1.04 .97 Atp6v1g2 KLA  ATP  ATP+KLA NM_023179 ATPase, H+ transporting, lysosomal V1 subunit G2 (Atp6v1g2), mRNA [NM_023179] KLA 1.12 1.09 1.03 1.05 1.16 1.15 1.01 ATP .96 1.01 .93 1.06 .85 .83 1.05 KLA/ATP 1.04 1.07 .99 1.07 .90 .82 .98 Atp6v1g3 KLA  ATP  ATP+KLA NM_177397 ATPase, H+ transporting, lysosomal V1 subunit G3 (Atp6v1g3), mRNA [NM_177397] KLA 1.05 1.03 1.00 .99 .97 1.02 1.00 ATP 1.04 1.07 1.02 .98 1.05 1.00 1.00 KLA/ATP .99 .98 1.01 1.02 1.03 1.01 1.05 Atp6v1h KLA  ATP  ATP+KLA AK081492 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130021C16 product:hypothetical V-ATPase subunit H containing protein, full insert sequence. [AK081492] KLA 1.09 .98 .77 .93 1.08 1.00 1.10 ATP 1.16 1.43 2.03 3.91 3.02 1.23 1.46 KLA/ATP 1.02 .98 1.06 2.30 2.07 1.28 1.06 Atp6v1h KLA  ATP  ATP+KLA NM_133826 ATPase, H+ transporting, lysosomal V1 subunit H (Atp6v1h), mRNA [NM_133826] KLA 1.13 1.15 1.12 1.05 1.05 .96 1.20 ATP 1.04 1.04 .86 1.06 2.07 2.38 1.90 KLA/ATP 1.14 1.17 .98 1.09 1.55 2.06 1.29 BC005774 KLA  ATP  ATP+KLA BC005774 cDNA clone MGC:12006 IMAGE:3602466, complete cds [BC005774] KLA .95 1.08 .93 1.05 .99 .98 .95 ATP 1.21 1.29 1.09 1.16 1.16 1.04 1.00 KLA/ATP .99 1.00 .92 1.02 1.00 .90 .91 C1r KLA  ATP  ATP+KLA NM_023143 complement component 1, r subcomponent (C1r), mRNA [NM_023143] KLA 8.09 7.91 7.94 8.52 7.04 6.64 3.85 ATP .96 .88 1.02 .92 .86 1.28 1.82 KLA/ATP 7.33 7.67 7.74 6.90 4.82 3.90 3.88 C3 KLA  ATP  ATP+KLA NM_009778 complement component 3 (C3), mRNA [NM_009778] KLA 28.58 25.57 24.39 27.34 23.38 23.21 18.10 ATP 1.04 .93 1.21 1.90 2.80 5.74 12.19 KLA/ATP 27.04 26.10 33.29 23.09 25.65 23.77 40.22 Calr KLA  ATP  ATP+KLA NM_007591 calreticulin (Calr), mRNA [NM_007591] KLA .86 .95 1.00 .68 .92 .93 1.37 ATP 1.12 1.34 .91 1.33 1.07 .97 1.46 KLA/ATP 1.09 1.02 .63 1.06 .65 .92 1.16 Canx KLA  ATP  ATP+KLA NM_007597 calnexin (Canx), transcript variant 1, mRNA [NM_007597] KLA 1.00 1.01 .92 .87 .85 .86 1.04 ATP 1.00 1.13 .97 1.04 .90 .75 .81 KLA/ATP 1.02 1.10 .82 .90 .63 .55 .60 Cd14 KLA  ATP  ATP+KLA NM_009841 CD14 antigen (Cd14), mRNA [NM_009841] KLA 2.35 2.68 2.54 2.21 2.39 1.52 1.57 ATP 1.44 2.28 2.82 3.98 6.68 16.14 6.92 KLA/ATP 2.92 3.79 3.96 5.12 5.29 10.42 11.50 Cd209a KLA  ATP  ATP+KLA NM_133238 CD209a antigen (Cd209a), mRNA [NM_133238] KLA .97 .98 1.09 .99 1.01 .96 1.02 ATP .97 1.00 1.12 .94 .96 .99 .89 KLA/ATP .99 1.03 1.08 1.01 1.01 1.08 1.01 Cd209b KLA  ATP  ATP+KLA NM_001037800 CD209b antigen (Cd209b), transcript variant 2, mRNA [NM_001037800] KLA 1.00 1.01 1.01 1.03 1.00 .97 1.04 ATP 1.00 1.03 1.02 .95 1.00 .91 .94 KLA/ATP .94 1.00 .96 .97 .98 1.02 1.05 Cd209c KLA  ATP  ATP+KLA NM_130903 CD209c antigen (Cd209c), mRNA [NM_130903] KLA 1.02 1.03 1.02 1.01 1.09 1.02 1.00 ATP .97 1.05 1.02 1.02 1.02 1.03 1.04 KLA/ATP .98 .95 1.09 1.02 .99 1.04 .99 Cd209d KLA  ATP  ATP+KLA NM_130904 CD209d antigen (Cd209d), mRNA [NM_130904] KLA .96 1.00 1.03 1.04 .95 .97 1.01 ATP .99 .97 .97 1.02 .97 .95 1.05 KLA/ATP 1.04 1.08 .99 1.02 .95 .99 1.05 Cd209e KLA  ATP  ATP+KLA NM_130905 CD209e antigen (Cd209e), mRNA [NM_130905] KLA 1.02 1.05 1.01 1.01 1.00 1.03 .96 ATP .96 .94 1.03 1.10 1.01 1.03 1.09 KLA/ATP .99 .99 .95 1.03 1.05 1.01 1.00 Cd36 KLA  ATP  ATP+KLA L23108 CD36 antigen mRNA, complete cds. [L23108] KLA .75 .74 .73 .57 .51 .40 .54 ATP .94 .93 .74 .61 .63 1.01 2.07 KLA/ATP .70 .67 .53 .47 .40 .58 1.13 Cd36 KLA  ATP  ATP+KLA NM_007643 CD36 antigen (Cd36), mRNA [NM_007643] KLA .70 .75 .67 .54 .45 .35 .42 ATP 1.06 1.04 .73 .58 .62 .81 1.44 KLA/ATP .83 .73 .45 .46 .35 .45 .82 Clec7a KLA  ATP  ATP+KLA NM_020008 C-type lectin domain family 7, member a (Clec7a), mRNA [NM_020008] KLA 1.00 1.09 1.13 1.28 1.06 .69 .23 ATP 1.11 1.37 1.80 1.74 2.19 5.15 3.56 KLA/ATP 1.09 1.37 2.08 2.11 2.41 3.22 2.40 Colec11 KLA  ATP  ATP+KLA NM_027866 collectin sub-family member 11 (Colec11), mRNA [NM_027866] KLA .98 1.02 1.01 1.06 .97 1.01 1.04 ATP 1.03 .99 1.02 1.42 1.57 1.03 1.04 KLA/ATP 1.03 1.02 1.07 1.50 1.77 1.73 1.19 Colec12 KLA  ATP  ATP+KLA NM_130449 collectin sub-family member 12 (Colec12), mRNA [NM_130449] KLA .99 1.01 .90 .91 .71 .58 .32 ATP .98 1.03 1.29 1.26 1.00 .74 .77 KLA/ATP .98 1.01 .97 1.17 .80 .65 .40 Comp KLA  ATP  ATP+KLA NM_016685 cartilage oligomeric matrix protein (Comp), mRNA [NM_016685] KLA 1.02 1.09 1.18 1.08 .96 1.12 .97 ATP .89 1.02 .97 .95 1.13 2.59 1.24 KLA/ATP 1.09 1.09 1.03 .98 1.60 2.02 1.15 Coro1a KLA  ATP  ATP+KLA NM_009898 coronin, actin binding protein 1A (Coro1a), mRNA [NM_009898] KLA .58 .61 .55 .50 .83 1.28 1.13 ATP 1.00 1.04 .46 .53 .33 .20 .74 KLA/ATP .65 .57 .24 .30 .20 .25 .74 Ctsl KLA  ATP  ATP+KLA NM_009984 cathepsin L (Ctsl), mRNA [NM_009984] KLA .85 .79 .72 .80 .79 .84 .75 ATP 1.02 1.01 1.16 .87 1.73 3.14 6.44 KLA/ATP .72 .80 1.12 .89 1.20 2.53 3.79 Ctss KLA  ATP  ATP+KLA NM_021281 cathepsin S (Ctss), mRNA [NM_021281] KLA 1.10 1.10 1.12 1.19 1.11 1.43 2.02 ATP .98 .91 1.04 .79 .87 1.01 1.82 KLA/ATP 1.05 .97 1.18 .98 1.12 1.24 2.03 Cyba KLA  ATP  ATP+KLA NM_007806 cytochrome b-245, alpha polypeptide (Cyba), mRNA [NM_007806] KLA 1.02 1.05 1.06 .91 1.03 1.04 1.68 ATP 1.05 1.11 1.00 1.36 1.10 .95 1.21 KLA/ATP 1.03 1.11 .93 1.31 1.01 1.03 1.47 Cybb KLA  ATP  ATP+KLA NM_007807 cytochrome b-245, beta polypeptide (Cybb), mRNA [NM_007807] KLA 5.43 5.43 5.59 5.19 5.71 5.00 5.08 ATP 1.08 1.18 1.19 1.64 1.68 2.73 1.82 KLA/ATP 5.34 5.62 4.98 6.75 3.74 3.36 3.96 Dync1h1 KLA  ATP  ATP+KLA NM_030238 dynein cytoplasmic 1 heavy chain 1 (Dync1h1), mRNA [NM_030238] KLA 1.78 1.64 2.10 1.64 1.91 1.55 1.26 ATP 1.16 1.06 1.00 .56 1.07 1.46 1.19 KLA/ATP 1.98 1.98 1.86 1.05 1.64 1.66 1.75 Dync1h1 KLA  ATP  ATP+KLA Z83808 gb|M.musculus mRNA for cytoplasmic dynein heavy chain (partial, ID mdhc10). [Z83808] KLA 1.48 1.24 1.23 1.53 1.45 1.52 1.26 ATP 1.13 1.04 .97 1.04 1.10 1.31 1.09 KLA/ATP 1.55 1.62 1.64 1.29 1.30 1.33 1.35 Dync1i1 KLA  ATP  ATP+KLA NM_010063 dynein cytoplasmic 1 intermediate chain 1 (Dync1i1), mRNA [NM_010063] KLA .81 .84 .79 .81 .84 .85 .93 ATP 1.05 1.00 .92 .96 .85 .82 .91 KLA/ATP .88 .84 .86 .79 .80 .81 .97 Dync1i2 KLA  ATP  ATP+KLA NM_010064 dynein cytoplasmic 1 intermediate chain 2 (Dync1i2), mRNA [NM_010064] KLA 2.07 2.25 2.75 2.53 2.86 2.50 1.24 ATP 1.03 1.12 .99 1.05 .88 .92 1.60 KLA/ATP 2.16 2.32 2.03 2.39 1.81 1.77 2.27 Dync1li1 KLA  ATP  ATP+KLA NM_146229 dynein cytoplasmic 1 light intermediate chain 1 (Dync1li1), mRNA [NM_146229] KLA 1.59 1.52 1.69 1.43 1.36 1.25 1.27 ATP 1.23 1.44 1.25 1.78 1.97 1.33 1.27 KLA/ATP 1.72 1.86 1.35 2.03 1.57 1.58 1.52 Dync1li2 KLA  ATP  ATP+KLA AK140743 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130001C04 product:Dynein light intermediate chain 2, cytosolic (LIC53 [AK140743] KLA .51 .51 .43 .50 .70 .76 .89 ATP .98 .82 .67 .45 .62 .68 .71 KLA/ATP .49 .46 .36 .32 .55 .48 .51 Dync1li2 KLA  ATP  ATP+KLA NM_001013380 dynein, cytoplasmic 1 light intermediate chain 2 (Dync1li2), mRNA [NM_001013380] KLA 1.11 1.12 1.12 1.10 1.28 1.37 1.41 ATP 1.00 1.04 .93 .97 1.06 1.52 1.75 KLA/ATP 1.12 1.18 1.00 1.10 1.03 1.32 2.18 Dync2h1 KLA  ATP  ATP+KLA NM_029851 dynein cytoplasmic 2 heavy chain 1 (Dync2h1), mRNA [NM_029851] KLA 1.12 1.12 1.20 1.24 1.30 1.32 .94 ATP 1.04 .96 .89 .71 .71 1.08 .92 KLA/ATP 1.09 1.10 1.09 .89 .94 1.34 1.36 EG629860 KLA  ATP  ATP+KLA M17953 gb|Mouse Ig rearranged H-chain V-region mRNA VJ1 [M17953] KLA .96 1.05 1.03 1.08 1.08 1.02 .98 ATP .97 .99 1.05 1.10 .95 .94 .91 KLA/ATP .96 .94 .97 1.04 .97 1.01 .89 Eea1 KLA  ATP  ATP+KLA NM_001001932 early endosome antigen 1 (Eea1), mRNA [NM_001001932] KLA .88 .83 .77 .79 1.02 .99 .86 ATP 1.09 1.19 1.09 1.47 1.83 1.20 .99 KLA/ATP .92 .90 .82 1.05 1.17 1.03 .82 Fcgr1 KLA  ATP  ATP+KLA AF143181 strain AB/H (Biozzi) high affinity immunoglobulin gamma Fc receptor I (Fcgr1) mRNA, Fcgr1-d allele, complete cds. [AF143181] KLA 4.27 4.21 5.59 6.14 8.13 9.76 10.98 ATP 1.23 1.12 1.08 1.36 1.09 2.09 11.81 KLA/ATP 4.56 4.93 4.95 5.88 6.66 9.64 23.09 Fcgr1 KLA  ATP  ATP+KLA NM_010186 Fc receptor, IgG, high affinity I (Fcgr1), mRNA [NM_010186] KLA 4.31 4.37 4.70 5.97 6.59 10.06 8.67 ATP 1.01 .88 1.16 .89 .90 2.15 9.23 KLA/ATP 4.01 4.10 5.52 4.54 6.31 9.24 15.83 Fcgr2b KLA  ATP  ATP+KLA NM_001077189 Fc receptor, IgG, low affinity IIb (Fcgr2b), transcript variant 1, mRNA [NM_001077189] KLA 16.93 17.57 21.75 27.43 34.13 31.88 5.70 ATP 1.11 1.09 1.17 1.46 2.81 11.26 1.92 KLA/ATP 16.51 17.91 23.67 29.22 22.67 25.33 9.54 Fcgr2b KLA  ATP  ATP+KLA NM_010187 Fc receptor, IgG, low affinity IIb (Fcgr2b), transcript variant 2, mRNA [NM_010187] KLA 11.41 11.67 14.06 15.47 17.28 18.63 4.69 ATP 1.05 1.06 1.18 1.57 2.27 8.97 2.10 KLA/ATP 10.98 12.01 15.03 18.38 15.15 16.00 8.33 Fcgr3 KLA  ATP  ATP+KLA NM_010188 Fc receptor, IgG, low affinity III (Fcgr3), mRNA [NM_010188] KLA 1.35 1.47 1.87 1.77 2.39 2.34 1.13 ATP 1.04 1.10 .99 1.14 1.01 1.55 1.90 KLA/ATP 1.50 1.53 1.53 1.99 1.61 2.38 2.69 Fcgr4 KLA  ATP  ATP+KLA NM_144559 Fc receptor, IgG, low affinity IV (Fcgr4), mRNA [NM_144559] KLA 9.03 8.68 9.82 11.51 11.12 13.01 7.95 ATP 1.04 .95 1.22 1.43 1.17 2.80 4.48 KLA/ATP 8.63 8.84 11.99 11.84 12.40 13.56 12.31 H2-Aa KLA  ATP  ATP+KLA NM_010378 histocompatibility 2, class II antigen A, alpha (H2-Aa), mRNA [NM_010378] KLA 1.43 1.59 1.68 1.50 1.62 1.89 1.64 ATP 1.07 1.15 1.27 1.90 1.92 1.77 1.55 KLA/ATP 1.62 1.81 1.74 2.29 1.89 1.92 2.19 H2-Ab1 KLA  ATP  ATP+KLA BC010322 histocompatibility 2, class II antigen A, beta 1, mRNA (cDNA clone MGC:6297 IMAGE:2651058), complete cds [BC010322] KLA 1.73 1.76 1.77 1.55 1.95 2.10 2.27 ATP 1.03 1.18 1.32 1.99 1.79 1.56 1.61 KLA/ATP 1.70 2.01 1.74 2.52 1.58 2.01 2.75 H2-Ab1 KLA  ATP  ATP+KLA NM_207105 histocompatibility 2, class II antigen A, beta 1 (H2-Ab1), mRNA [NM_207105] KLA 2.02 2.15 2.07 2.09 2.32 2.78 3.08 ATP 1.11 1.20 1.42 2.33 2.33 2.25 1.87 KLA/ATP 2.11 2.32 2.52 3.62 2.67 2.96 5.04 H2-Bl KLA  ATP  ATP+KLA NM_008199 histocompatibility 2, blastocyst (H2-Bl), mRNA [NM_008199] KLA 1.29 1.32 1.40 1.28 1.36 1.46 1.80 ATP 1.04 1.11 1.02 1.34 1.28 1.32 1.47 KLA/ATP 1.32 1.39 1.34 1.77 1.41 1.61 2.39 H2-D1 KLA  ATP  ATP+KLA AK169750 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:E430019E13 product:histocompatibility 2, D region locus 1, full insert sequence [AK169750] KLA .99 .98 .96 .99 .93 .91 .94 ATP .96 1.01 1.02 .95 1.05 1.00 .98 KLA/ATP .92 .94 .97 .97 .98 .92 1.03 H2-D1 KLA  ATP  ATP+KLA NM_010380 histocompatibility 2, D region locus 1 (H2-D1), mRNA [NM_010380] KLA 1.38 1.45 1.73 1.42 1.70 1.76 2.56 ATP 1.15 1.11 .86 1.12 1.19 1.28 1.90 KLA/ATP 1.58 1.72 1.38 1.56 1.38 1.69 3.21 H2-DMa KLA  ATP  ATP+KLA NM_010386 histocompatibility 2, class II, locus DMa (H2-DMa), mRNA [NM_010386] KLA 1.49 1.50 1.65 1.65 1.91 2.23 1.69 ATP 1.04 1.12 1.26 1.67 1.24 .99 1.32 KLA/ATP 1.58 1.68 1.70 2.02 1.37 1.35 1.90 H2-DMb1 KLA  ATP  ATP+KLA NM_010387 histocompatibility 2, class II, locus Mb1 (H2-DMb1), mRNA [NM_010387] KLA 1.06 1.14 1.08 1.13 1.24 1.41 1.37 ATP 1.01 1.02 1.09 1.14 .92 .73 1.36 KLA/ATP 1.13 1.05 1.21 1.17 .98 .83 1.41 H2-DMb2 KLA  ATP  ATP+KLA NM_010388 histocompatibility 2, class II, locus Mb2 (H2-DMb2), mRNA [NM_010388] KLA 1.00 1.04 .93 .95 .96 .95 1.03 ATP 1.06 1.04 .94 .92 .97 .95 1.00 KLA/ATP .90 .94 .99 .94 .90 .96 .92 H2-Eb1 KLA  ATP  ATP+KLA X52641 gb|Mouse mRNA for I-A beta NOD. [X52641] KLA 1.94 2.06 1.94 1.87 1.96 2.18 1.76 ATP 1.11 1.20 1.53 2.70 3.02 2.91 1.40 KLA/ATP 2.09 2.11 2.26 3.55 2.76 3.05 3.05 H2-K1 KLA  ATP  ATP+KLA M69070 mRNA, complete cds. [M69070] KLA 1.76 1.66 1.78 1.78 1.87 2.23 2.99 ATP .98 .97 1.19 1.45 1.36 1.68 2.17 KLA/ATP 1.68 1.70 1.87 1.96 1.87 2.13 3.82 H2-K1 KLA  ATP  ATP+KLA NM_001001892 histocompatibility 2, K1, K region (H2-K1), transcript variant 1, mRNA [NM_001001892] KLA 1.82 1.66 1.73 1.76 1.87 2.29 3.17 ATP .98 .97 1.13 1.32 1.29 1.57 2.09 KLA/ATP 1.64 1.71 1.77 1.82 1.71 2.12 3.91 H2-M1 KLA  ATP  ATP+KLA NM_177636 histocompatibility 2, M region locus 1 (H2-M1), mRNA [NM_177636] KLA .99 1.01 1.02 1.02 .97 1.03 1.04 ATP 1.01 .99 1.03 1.07 .92 1.03 .98 KLA/ATP 1.08 .97 .94 1.04 1.00 1.04 1.02 H2-M10.1 KLA  ATP  ATP+KLA NM_013544 histocompatibility 2, M region locus 10.1 (H2-M10.1), mRNA [NM_013544] KLA 1.04 1.00 1.05 .95 .98 1.04 .94 ATP 1.06 1.04 .96 .95 .97 .98 .98 KLA/ATP 1.02 1.07 .98 1.02 .92 .92 .99 H2-M10.2 KLA  ATP  ATP+KLA NM_177923 histocompatibility 2, M region locus 10.2 (H2-M10.2), mRNA [NM_177923] KLA 2.18 2.23 2.51 2.61 2.90 3.30 3.40 ATP 1.08 1.02 1.22 1.39 1.30 1.56 2.66 KLA/ATP 2.23 2.53 2.82 2.91 2.89 2.60 3.92 H2-M10.3 KLA  ATP  ATP+KLA AY211080 major histocompatibility complex class Ib M10.3 mRNA, complete cds [AY211080] KLA .95 1.08 .99 .95 1.00 1.11 1.04 ATP .98 .96 1.00 .99 1.00 .99 1.00 KLA/ATP 1.00 .99 1.00 1.00 .99 .96 1.03 H2-M10.4 KLA  ATP  ATP+KLA NM_177634 histocompatibility 2, M region locus 10.4 (H2-M10.4), mRNA [NM_177634] KLA 1.03 1.04 1.08 1.08 1.04 1.03 1.03 ATP 1.07 1.05 .97 1.08 .95 .97 1.02 KLA/ATP 1.02 .97 1.02 .99 .93 1.06 1.04 H2-M10.5 KLA  ATP  ATP+KLA NM_177637 histocompatibility 2, M region locus 10.5 (H2-M10.5), mRNA [NM_177637] KLA 1.00 1.04 1.13 .93 .99 1.00 1.07 ATP 1.02 1.02 1.04 .90 1.03 .99 .99 KLA/ATP 1.06 1.03 .97 1.03 1.03 .98 1.04 H2-M10.6 KLA  ATP  ATP+KLA NM_201611 histocompatibility 2, M region locus 10.6 (H2-M10.6), mRNA [NM_201611] KLA 1.06 .99 1.04 1.06 .98 1.03 .92 ATP 1.04 1.09 .96 .98 .94 1.07 .98 KLA/ATP 1.01 1.06 1.02 .96 .96 1.04 1.05 H2-M11 KLA  ATP  ATP+KLA NM_177635 histocompatibility 2, M region locus 11 (H2-M11), mRNA [NM_177635] KLA 1.03 1.07 1.06 1.02 .96 1.05 1.03 ATP 1.02 .96 1.08 .98 1.04 .94 .98 KLA/ATP 1.03 1.03 .99 1.01 1.01 .98 .99 H2-M3 KLA  ATP  ATP+KLA NM_013819 histocompatibility 2, M region locus 3 (H2-M3), mRNA [NM_013819] KLA 1.90 2.04 2.09 2.37 2.30 2.56 2.73 ATP 1.00 1.00 1.19 1.34 1.00 .70 1.09 KLA/ATP 1.77 1.94 2.37 2.49 1.89 1.67 2.06 H2-M9 KLA  ATP  ATP+KLA NM_008205 histocompatibility 2, M region locus 9 (H2-M9), mRNA [NM_008205] KLA 1.03 .99 .96 .98 1.01 .99 1.03 ATP .96 1.06 .94 .96 1.05 1.06 1.00 KLA/ATP .96 1.01 1.01 .99 .97 .95 .98 H2-Oa KLA  ATP  ATP+KLA NM_008206 histocompatibility 2, O region alpha locus (H2-Oa), mRNA [NM_008206] KLA 1.22 1.32 1.37 1.33 1.31 1.26 1.53 ATP 1.02 1.05 1.16 1.21 1.12 1.07 1.16 KLA/ATP 1.32 1.34 1.31 1.34 1.25 1.35 2.78 H2-Ob KLA  ATP  ATP+KLA NM_010389 histocompatibility 2, O region beta locus (H2-Ob), mRNA [NM_010389] KLA 1.05 1.07 1.01 .96 1.10 1.02 1.00 ATP 1.04 .99 1.00 1.03 .94 1.07 .94 KLA/ATP 1.02 .97 1.06 1.08 1.00 .96 1.05 H2-Q1 KLA  ATP  ATP+KLA NM_010390 histocompatibility 2, Q region locus 1 (H2-Q1), mRNA [NM_010390] KLA 1.05 1.08 1.03 1.02 .98 1.09 1.00 ATP .99 .92 .93 1.01 1.01 1.04 1.00 KLA/ATP 1.07 1.00 1.00 .91 .97 1.07 1.04 H2-Q10 KLA  ATP  ATP+KLA NM_010391 histocompatibility 2, Q region locus 10 (H2-Q10), mRNA [NM_010391] KLA 1.50 1.50 1.70 1.64 1.67 1.79 2.18 ATP 1.12 1.11 1.09 1.46 1.42 1.43 1.69 KLA/ATP 1.61 1.72 1.79 1.94 1.81 1.81 2.93 H2-Q2 KLA  ATP  ATP+KLA NM_010392 histocompatibility 2, Q region locus 2 (H2-Q2), mRNA [NM_010392] KLA 1.55 1.52 1.61 1.45 1.83 1.94 2.47 ATP 1.09 1.13 .92 1.16 1.17 1.30 1.88 KLA/ATP 1.55 1.70 1.58 1.80 1.64 1.87 3.43 H2-Q7 KLA  ATP  ATP+KLA NM_010394 histocompatibility 2, Q region locus 7 (H2-Q7), mRNA [NM_010394] KLA 1.57 1.58 1.74 1.55 1.82 2.00 2.76 ATP 1.05 1.09 .84 1.12 1.12 1.23 2.00 KLA/ATP 1.63 1.75 1.43 1.67 1.53 1.80 3.48 H2-Q8 KLA  ATP  ATP+KLA NM_023124 histocompatibility 2, Q region locus 8 (H2-Q8), mRNA [NM_023124] KLA 7.48 6.46 6.41 7.15 7.46 9.60 18.27 ATP 1.01 .98 1.48 2.05 1.93 3.83 8.26 KLA/ATP 6.72 7.10 9.11 10.95 10.71 12.88 31.43 H2-T22 KLA  ATP  ATP+KLA NM_010397 histocompatibility 2, T region locus 22 (H2-T22), mRNA [NM_010397] KLA 5.21 5.40 5.81 6.31 7.42 9.49 7.50 ATP 1.01 .95 .88 .92 .93 3.65 5.53 KLA/ATP 4.83 5.12 4.58 4.74 4.81 6.89 14.89 H2-T23 KLA  ATP  ATP+KLA NM_010398 histocompatibility 2, T region locus 23 (H2-T23), mRNA [NM_010398] KLA 1.83 1.80 1.92 1.86 2.32 2.56 3.43 ATP 1.03 1.08 .85 1.18 1.09 1.30 2.49 KLA/ATP 1.76 1.92 1.62 1.93 1.76 2.13 4.06 H2-T24 KLA  ATP  ATP+KLA NM_008207 histocompatibility 2, T region locus 24 (H2-T24), mRNA [NM_008207] KLA 3.02 3.26 4.14 4.26 5.15 6.06 5.89 ATP 1.08 1.09 1.32 1.35 1.17 1.71 6.71 KLA/ATP 3.23 3.31 3.54 3.85 3.07 3.73 9.10 H2-T3 KLA  ATP  ATP+KLA NM_008208 histocompatibility 2, T region locus 3 (H2-T3), mRNA [NM_008208] KLA .95 1.04 1.00 .97 .97 .99 1.00 ATP .98 1.08 1.03 1.01 .98 1.02 1.03 KLA/ATP 1.05 .96 1.02 1.04 1.05 1.00 .97 Hgs KLA  ATP  ATP+KLA NM_008244 HGF-regulated tyrosine kinase substrate (Hgs), mRNA [NM_008244] KLA 1.04 1.12 1.07 1.23 1.69 1.57 1.56 ATP 1.08 1.21 .92 1.20 1.45 2.05 1.41 KLA/ATP 1.12 1.30 .99 1.25 1.38 2.04 2.14 Igh-VJ55 8 KLA  ATP  ATP+KLA AY547436 immunoglobulin heavy chain VDJ region mRNA, partial cds [AY547436] KLA 1.06 1.05 1.01 .93 1.03 .96 .93 ATP .99 1.00 1.06 .95 .96 1.06 1.05 KLA/ATP .98 .94 1.07 .95 .97 .99 1.02 Igh-VJ55 8 KLA  ATP  ATP+KLA CA578712 gb|K0727F04-5N NIA Mouse Hematopoietic Stem Cell (Lin- [CA578712] KLA .99 .94 1.01 1.10 .93 .97 .92 ATP .93 1.04 1.01 .98 1.05 .96 .95 KLA/ATP .99 .95 .95 .98 1.02 .98 .95 Igh-VJ55 8 KLA  ATP  ATP+KLA ENSMUST00000103412 ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHA] [ENSMUST00000103412] KLA 1.01 .97 1.20 1.01 .98 1.44 1.24 ATP .99 .98 1.07 1.03 1.00 1.01 1.21 KLA/ATP .99 1.02 .96 1.03 .97 1.13 1.30 Igh-VJ55 8 KLA  ATP  ATP+KLA ENSMUST00000103413 ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHE] [ENSMUST00000103413] KLA 1.00 .99 1.06 1.06 .99 1.03 1.02 ATP 1.08 1.06 1.06 1.06 1.02 1.06 .95 KLA/ATP 1.00 1.04 1.09 1.02 1.06 1.02 .95 Igh-VJ55 8 KLA  ATP  ATP+KLA U39781 J558+ IgM heavy chain mRNA, hybridoma clone ME2B7, partial cds. [U39781] KLA .93 .89 .98 .97 1.03 1.00 .94 ATP 1.04 1.02 1.08 .94 .93 .90 .79 KLA/ATP .88 .89 .97 .93 .88 .92 .82 Itga2 KLA  ATP  ATP+KLA NM_008396 integrin alpha 2 (Itga2), mRNA [NM_008396] KLA 1.03 1.00 .98 1.01 .97 .96 1.00 ATP 1.05 .99 .93 1.02 1.04 1.03 .97 KLA/ATP .98 1.06 1.03 1.00 1.00 1.01 1.01 Itga5 KLA  ATP  ATP+KLA NM_010577 integrin alpha 5 (fibronectin receptor alpha) (Itga5), mRNA [NM_010577] KLA 2.63 3.04 2.81 2.47 4.61 5.45 4.90 ATP 1.13 1.62 .74 2.21 1.31 1.93 2.84 KLA/ATP 3.55 3.84 1.15 3.03 1.11 2.81 10.42 Itgam KLA  ATP  ATP+KLA NM_001082960 integrin alpha M (Itgam), transcript variant 1, mRNA [NM_001082960] KLA 1.04 1.12 1.14 1.07 1.54 1.80 1.72 ATP 1.17 1.19 .97 1.16 .86 .65 1.33 KLA/ATP 1.19 1.19 .94 1.06 .64 .59 1.08 Itgam KLA  ATP  ATP+KLA NM_008401 integrin alpha M (Itgam), transcript variant 2, mRNA [NM_008401] KLA 1.20 1.16 1.21 1.34 1.59 1.79 1.64 ATP 1.15 1.16 .94 1.20 1.00 .78 1.25 KLA/ATP 1.32 1.37 1.29 1.14 .84 .75 1.16 Itgav KLA  ATP  ATP+KLA AK052514 13 days embryo lung cDNA, RIKEN full-length enriched library, clone:D430040G12 product:hypothetical protein, full insert sequence. [AK052514] KLA 1.04 .93 1.05 1.02 1.01 .93 1.03 ATP 1.05 1.04 1.13 1.12 1.12 .91 1.02 KLA/ATP 1.08 .97 1.02 .95 1.01 .96 1.05 Itgav KLA  ATP  ATP+KLA AK171739 activated spleen cDNA, RIKEN full-length enriched library, clone:F830008B15 product:unclassifiable, full insert sequence. [AK171739] KLA 1.04 .97 1.06 .95 1.15 .89 1.11 ATP 1.41 1.54 1.64 2.24 2.74 1.24 1.18 KLA/ATP 1.09 1.07 1.03 1.01 1.72 1.24 1.10 Itgav KLA  ATP  ATP+KLA NM_008402 integrin alpha V (Itgav), mRNA [NM_008402] KLA 4.00 3.99 3.28 2.24 1.57 .95 1.13 ATP 1.14 1.22 1.13 1.39 2.22 2.47 1.70 KLA/ATP 4.59 4.61 2.48 2.44 1.60 1.88 2.56 Itgb1 KLA  ATP  ATP+KLA NM_010578 integrin beta 1 (fibronectin receptor beta) (Itgb1), mRNA [NM_010578] KLA 1.05 1.09 1.13 .92 1.01 .93 .88 ATP 1.14 1.30 .92 1.07 1.04 .83 .70 KLA/ATP 1.26 1.30 .87 1.02 .66 .65 .62 Itgb1 KLA  ATP  ATP+KLA U37029 integrin beta1D mRNA, partial cds. [U37029] KLA .93 .95 .96 1.01 .97 1.01 .98 ATP 1.05 .99 .99 1.03 1.03 .97 .94 KLA/ATP .99 .98 1.04 .97 1.02 1.01 .99 Itgb2 KLA  ATP  ATP+KLA NM_008404 integrin beta 2 (Itgb2), mRNA [NM_008404] KLA .78 .78 .97 .74 1.04 .94 1.14 ATP 1.24 1.23 .79 .95 1.12 .84 1.10 KLA/ATP .99 1.01 .60 .83 .78 .73 .99 Itgb2l KLA  ATP  ATP+KLA NM_008405 integrin beta 2-like (Itgb2l), mRNA [NM_008405] KLA .87 .98 .98 1.00 1.05 1.07 1.10 ATP 1.24 1.23 1.13 1.14 1.29 1.05 1.05 KLA/ATP 1.02 1.08 1.08 1.06 .98 .93 .95 Itgb3 KLA  ATP  ATP+KLA AF026509 integrin beta3 subunit mRNA, complete cds. [AF026509] KLA 2.38 2.64 2.65 3.15 4.02 4.46 2.83 ATP 1.21 1.17 1.25 1.62 2.33 3.09 4.78 KLA/ATP 2.48 2.63 3.39 3.72 4.30 4.71 6.79 Itgb3 KLA  ATP  ATP+KLA NM_016780 integrin beta 3 (Itgb3), mRNA [NM_016780] KLA .50 .51 .52 .41 .31 .25 .15 ATP .94 .88 1.17 .89 .99 1.36 .91 KLA/ATP .51 .54 .67 .52 .61 .74 .48 Itgb5 KLA  ATP  ATP+KLA NM_010580 integrin beta 5 (Itgb5), mRNA [NM_010580] KLA .72 .68 .67 .66 .54 .43 .36 ATP 1.09 .94 .78 .57 .63 .56 .62 KLA/ATP .78 .64 .67 .51 .64 .67 .38 LOC67670 8 KLA  ATP  ATP+KLA XM_992322 ref|PREDICTED: Mus musculus similar to class I (Qa) Q2k antigen (LOC676708), mRNA [XM_992322] KLA 2.18 2.22 2.32 2.27 2.28 2.77 3.62 ATP 1.04 1.17 1.17 2.19 1.83 1.75 2.30 KLA/ATP 2.20 2.44 2.25 3.41 2.30 2.63 5.00 Lamp1 KLA  ATP  ATP+KLA NM_010684 lysosomal-associated membrane protein 1 (Lamp1), mRNA [NM_010684] KLA .88 .89 .92 .83 .83 .86 1.10 ATP .98 1.02 .91 .87 .92 .94 1.31 KLA/ATP .88 .91 .81 .80 .78 .83 1.21 Lamp2 KLA  ATP  ATP+KLA NM_001017959 lysosomal-associated membrane protein 2 (Lamp2), transcript variant 1, mRNA [NM_001017959] KLA 1.14 1.12 1.25 1.30 1.21 1.30 1.12 ATP .98 .91 1.17 1.00 .91 1.00 .83 KLA/ATP 1.08 1.05 1.33 1.13 1.17 1.45 1.29 Lamp2 KLA  ATP  ATP+KLA NM_010685 lysosomal-associated membrane protein 2 (Lamp2), transcript variant 2, mRNA [NM_010685] KLA 1.28 1.27 1.42 1.54 1.36 1.50 1.14 ATP 1.03 .95 1.18 .77 .86 .80 .71 KLA/ATP 1.27 1.23 1.50 .91 1.00 .95 1.21 M6pr KLA  ATP  ATP+KLA NM_010749 mannose-6-phosphate receptor, cation dependent (M6pr), mRNA [NM_010749] KLA 1.70 1.73 1.86 1.55 2.23 2.42 1.82 ATP 1.08 1.25 1.03 .97 1.03 1.33 1.75 KLA/ATP 1.62 1.79 1.52 1.62 1.27 1.82 2.37 Marco KLA  ATP  ATP+KLA NM_010766 macrophage receptor with collagenous structure (Marco), mRNA [NM_010766] KLA 5.39 6.50 6.38 11.05 23.28 36.85 53.94 ATP .93 .79 1.33 1.28 1.94 8.78 6.37 KLA/ATP 5.19 5.99 7.21 6.01 6.86 9.16 20.57 Mbl1 KLA  ATP  ATP+KLA NM_010775 mannose binding lectin (A) (Mbl1), mRNA [NM_010775] KLA .97 1.06 .97 1.03 1.02 .99 .98 ATP 1.05 1.03 .95 1.00 .97 .93 .98 KLA/ATP 1.12 1.00 1.07 1.04 .92 1.02 .94 Mbl2 KLA  ATP  ATP+KLA NM_010776 mannose binding lectin (C) (Mbl2), mRNA [NM_010776] KLA 1.04 1.00 1.02 .96 .97 1.00 .96 ATP .98 1.00 .98 .93 .97 .93 .98 KLA/ATP 1.04 1.06 .99 .98 1.02 .94 1.05 Mm.17516 3 KLA  ATP  ATP+KLA 83699405 Unknown KLA .98 .99 1.01 .95 .99 1.06 .96 ATP 1.03 1.00 1.07 1.02 1.02 .98 .97 KLA/ATP 1.01 1.08 1.03 1.00 1.03 .93 .97 Mm.18143 0 KLA  ATP  ATP+KLA 134288916 Unknown KLA 1.92 1.66 1.89 1.74 1.97 1.74 1.15 ATP 1.14 .96 .93 .44 .91 1.60 1.19 KLA/ATP 1.77 1.70 2.16 .89 1.58 1.61 1.64 Mm.19506 1 KLA  ATP  ATP+KLA 76253707 Unknown KLA 5.35 4.83 5.36 6.20 6.87 9.80 7.83 ATP .97 .90 .96 .77 .80 3.98 5.87 KLA/ATP 4.63 4.51 4.51 3.75 4.39 7.21 16.38 Mm.29362 6 KLA  ATP  ATP+KLA 134053880 Unknown KLA 7.23 6.16 6.71 5.06 3.81 2.61 1.75 ATP 1.14 1.34 2.13 3.36 9.90 10.36 1.64 KLA/ATP 7.23 8.21 6.94 6.55 5.27 5.68 3.35 Mm.38049 KLA  ATP  ATP+KLA 118130391 Unknown KLA .67 .65 .73 .92 .63 .81 .76 ATP .93 .92 1.08 .54 .45 1.48 1.56 KLA/ATP .57 .65 .98 .67 .44 .78 1.16 Mm.42529 6 KLA  ATP  ATP+KLA 170172552 Unknown KLA 1.51 1.59 1.64 1.57 1.87 1.40 1.91 ATP 1.02 1.04 .77 .91 .52 .49 1.04 KLA/ATP 1.63 1.53 1.11 1.32 .80 .69 1.23 Mm.43967 5 KLA  ATP  ATP+KLA 133778954 Unknown KLA 1.76 1.74 1.70 1.72 1.75 2.14 3.19 ATP 1.00 1.01 1.18 1.28 1.25 1.48 1.84 KLA/ATP 1.67 1.64 1.70 1.79 1.63 2.04 3.36 Mm.43967 5 KLA  ATP  ATP+KLA 149275074 Unknown KLA 2.17 2.23 2.26 2.58 2.26 2.10 1.43 ATP .96 .91 1.12 .90 .70 1.10 1.47 KLA/ATP 1.96 2.10 1.92 1.51 1.12 1.35 1.99 Mm.44165 1 KLA  ATP  ATP+KLA 160333403 Unknown KLA 5.45 5.27 5.02 6.34 6.63 10.05 8.10 ATP .91 .84 .96 .75 .78 3.91 6.03 KLA/ATP 4.29 4.38 4.50 3.55 4.22 7.22 17.63 Mm.47066 1 KLA  ATP  ATP+KLA 111186463 Unknown KLA .51 .50 .47 .50 .45 .54 .62 ATP 1.07 .92 .91 .65 .66 .43 .29 KLA/ATP .52 .41 .51 .38 .40 .34 .18 Mm.47212 1 KLA  ATP  ATP+KLA 142378376 Unknown KLA .63 .70 .63 .67 .54 .48 .49 ATP .89 1.10 1.23 1.18 2.76 3.35 .36 KLA/ATP .69 .84 .94 .91 2.11 2.31 .25 Mm.5092 KLA  ATP  ATP+KLA 6679364 Unknown KLA 1.66 1.91 1.84 1.77 1.67 2.24 1.50 ATP 1.03 1.01 1.08 1.00 .91 .86 .86 KLA/ATP 1.74 1.72 1.71 1.43 1.12 1.07 1.15 Mpo KLA  ATP  ATP+KLA NM_010824 myeloperoxidase (Mpo), nuclear gene encoding mitochondrial protein, mRNA [NM_010824] KLA 1.13 1.22 1.15 1.19 .97 .97 1.07 ATP .92 1.06 1.50 1.90 1.74 1.21 .86 KLA/ATP 1.20 1.36 1.48 1.94 2.16 1.84 .95 Mrc1 KLA  ATP  ATP+KLA NM_008625 mannose receptor, C type 1 (Mrc1), mRNA [NM_008625] KLA .57 .50 .60 .48 .28 .10 .01 ATP 1.12 1.05 1.03 .65 .57 .31 .23 KLA/ATP .57 .57 .58 .36 .21 .14 .04 Mrc2 KLA  ATP  ATP+KLA NM_008626 mannose receptor, C type 2 (Mrc2), mRNA [NM_008626] KLA 1.02 1.01 1.07 1.08 1.00 1.00 1.04 ATP .99 .93 1.08 1.04 1.03 .95 1.12 KLA/ATP 1.03 1.04 1.04 1.13 1.15 1.08 .98 Msr1 KLA  ATP  ATP+KLA NM_031195 macrophage scavenger receptor 1 (Msr1), transcript variant 1, mRNA [NM_031195] KLA 3.19 3.19 3.21 3.48 4.16 4.53 3.96 ATP 1.07 1.12 1.22 1.34 1.43 2.20 5.52 KLA/ATP 3.29 3.34 3.43 3.91 3.08 2.63 5.41 Ncf1 KLA  ATP  ATP+KLA NM_010876 neutrophil cytosolic factor 1 (Ncf1), mRNA [NM_010876] KLA 1.62 1.71 1.81 1.70 1.99 1.64 2.07 ATP 1.02 1.06 .78 1.02 .64 .56 1.08 KLA/ATP 1.87 1.81 1.22 1.73 1.00 .80 1.49 Ncf2 KLA  ATP  ATP+KLA NM_010877 neutrophil cytosolic factor 2 (Ncf2), mRNA [NM_010877] KLA .74 .69 .81 .83 1.07 1.20 .89 ATP 1.21 1.13 .91 1.00 .91 1.82 1.19 KLA/ATP .80 .74 .62 .70 .71 1.26 1.27 Ncf4 KLA  ATP  ATP+KLA NM_008677 neutrophil cytosolic factor 4 (Ncf4), mRNA [NM_008677] KLA 1.23 1.30 1.19 1.45 1.88 2.46 2.29 ATP .97 .83 .83 .87 1.25 1.99 3.67 KLA/ATP 1.21 1.11 1.04 1.13 1.48 1.70 2.60 Nos1 KLA  ATP  ATP+KLA NM_008712 nitric oxide synthase 1, neuronal (Nos1), mRNA [NM_008712] KLA 1.01 1.01 1.02 .99 1.02 1.02 1.01 ATP 1.01 1.03 1.02 1.04 1.03 1.01 1.00 KLA/ATP 1.05 1.02 1.02 1.00 1.02 1.03 1.03 Nox1 KLA  ATP  ATP+KLA NM_172203 NADPH oxidase 1 (Nox1), mRNA [NM_172203] KLA 2.18 2.93 3.44 2.51 2.84 1.77 1.10 ATP 1.01 .99 1.13 1.21 1.09 1.00 1.03 KLA/ATP 3.07 3.07 1.88 2.30 1.55 1.60 1.14 Nox3 KLA  ATP  ATP+KLA NM_198958 NADPH oxidase 3 (Nox3), mRNA [NM_198958] KLA .98 .99 1.01 1.00 1.01 1.07 1.04 ATP 1.04 .95 .95 .96 1.02 .97 .92 KLA/ATP .99 1.03 .93 .99 .93 .95 .99 Olr1 KLA  ATP  ATP+KLA NM_138648 oxidized low density lipoprotein (lectin-like) receptor 1 (Olr1), mRNA [NM_138648] KLA 9.12 7.68 5.64 4.63 2.87 1.85 1.54 ATP 1.02 1.09 1.74 2.37 13.70 19.09 1.53 KLA/ATP 8.82 9.30 6.77 5.14 4.08 4.72 2.37 Pik3c3 KLA  ATP  ATP+KLA NM_181414 phosphoinositide-3-kinase, class 3 (Pik3c3), mRNA [NM_181414] KLA .85 .82 .90 .91 .99 1.01 .87 ATP .92 1.02 .97 1.08 .60 .82 .87 KLA/ATP .80 .86 .79 .90 .66 .94 .92 Pip5k3 KLA  ATP  ATP+KLA NM_011086 phosphatidylinositol-3-phosphate/phosphatidylinositol 5-kinase, type III (Pip5k3), mRNA [NM_011086] KLA 2.92 2.86 2.69 1.86 1.49 1.25 1.14 ATP 1.15 1.23 1.19 1.19 1.63 1.06 1.18 KLA/ATP 3.09 3.42 2.64 2.17 1.71 1.25 1.14 Pla2r1 KLA  ATP  ATP+KLA NM_008867 phospholipase A2 receptor 1 (Pla2r1), mRNA [NM_008867] KLA 3.76 3.70 4.27 2.95 3.36 4.69 1.93 ATP 1.02 1.09 1.40 1.01 .76 .64 .71 KLA/ATP 3.72 3.92 4.28 2.95 1.60 1.12 1.78 Rab5a KLA  ATP  ATP+KLA AK036011 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630027A13 product:hypothetical protein, full insert sequence. [AK036011] KLA .98 1.01 .98 .93 1.04 .95 1.02 ATP 1.01 1.02 1.03 .96 1.08 1.04 1.08 KLA/ATP 1.06 1.02 1.02 .92 .99 1.01 1.08 Rab5a KLA  ATP  ATP+KLA NM_025887 RAB5A, member RAS oncogene family (Rab5a), mRNA [NM_025887] KLA 1.88 1.84 2.12 2.01 1.68 1.40 1.18 ATP 1.00 .95 .93 .81 1.10 1.57 1.09 KLA/ATP 1.87 1.86 1.87 1.72 1.71 1.63 1.47 Rab5b KLA  ATP  ATP+KLA AK144551 adult male intestinal mucosa cDNA, RIKEN full-length enriched library, clone:G630095F06 product:RAB5B, member RAS oncogene family, full insert sequence. [AK144551] KLA .84 .93 1.00 .83 1.07 .95 1.19 ATP 1.11 1.01 .75 .84 .97 .93 .88 KLA/ATP .95 .87 .64 .88 .98 .99 .93 Rab5b KLA  ATP  ATP+KLA NM_011229 RAB5B, member RAS oncogene family (Rab5b), mRNA [NM_011229] KLA 1.07 1.13 1.29 1.05 1.14 1.06 1.16 ATP 1.15 1.16 .78 .83 .93 .92 1.15 KLA/ATP 1.22 1.15 .77 .86 .87 .93 1.30 Rab5b KLA  ATP  ATP+KLA NM_177411 RAB5B, member RAS oncogene family (Rab5b), mRNA [NM_177411] KLA 1.38 1.33 1.46 1.18 1.23 1.31 1.30 ATP 1.07 1.32 .83 1.08 .71 1.02 1.34 KLA/ATP 1.57 1.58 .95 1.38 .76 1.04 1.55 Rab5c KLA  ATP  ATP+KLA NM_024456 RAB5C, member RAS oncogene family (Rab5c), mRNA [NM_024456] KLA .96 1.26 1.45 1.13 1.14 1.50 1.17 ATP .95 1.30 1.32 1.01 .98 1.03 1.04 KLA/ATP 1.11 1.37 1.61 1.15 1.00 1.18 1.52 Rab7 KLA  ATP  ATP+KLA BI654107 gb|603280186F1 NCI_CGAP_Mam4 Mus musculus cDNA clone IMAGE:5310477 5, mRNA sequence [BI654107] KLA 1.08 1.15 1.33 1.10 1.13 1.26 1.24 ATP .99 1.11 1.08 1.39 1.49 1.69 2.44 KLA/ATP 1.19 1.17 1.12 1.51 1.30 1.77 2.20 Rab7 KLA  ATP  ATP+KLA DV064670 gb|NEONATAL_23_D05.x1 FH NEONATAL Mus musculus cDNA clone NEONATAL_23_D05 similar to RAB7 member RAS oncogene family, mRNA sequence [DV064670] KLA 1.01 1.03 1.05 .90 .94 .97 1.09 ATP 1.05 1.16 1.00 1.26 1.36 1.36 1.97 KLA/ATP 1.16 1.08 .77 1.23 1.12 1.41 1.50 Rac1 KLA  ATP  ATP+KLA NM_009007 RAS-related C3 botulinum substrate 1 (Rac1), mRNA [NM_009007] KLA 1.02 1.01 1.02 .99 1.03 1.15 1.08 ATP .99 1.15 1.01 1.27 1.06 1.20 1.06 KLA/ATP 1.00 1.04 .88 1.16 .91 1.21 1.38 Rilp KLA  ATP  ATP+KLA NM_001029938 Rab interacting lysosomal protein (Rilp), mRNA [NM_001029938] KLA .76 .77 .73 .70 .65 .66 .65 ATP 1.10 1.03 .93 1.12 .89 .78 .94 KLA/ATP .85 .79 .93 .83 .75 .65 .72 Scarb1 KLA  ATP  ATP+KLA NM_016741 scavenger receptor class B, member 1 (Scarb1), mRNA [NM_016741] KLA .62 .60 .60 .51 .45 .40 .48 ATP 1.04 1.14 .68 .89 .53 .46 .82 KLA/ATP .73 .67 .40 .55 .34 .30 .39 Sec22b KLA  ATP  ATP+KLA NM_011342 SEC22 vesicle trafficking protein homolog B (S. cerevisiae) (Sec22b), mRNA [NM_011342] KLA 1.18 1.18 1.22 1.35 1.29 1.23 1.19 ATP 1.06 1.03 1.09 1.02 1.34 2.84 1.53 KLA/ATP 1.17 1.27 1.42 1.29 1.28 1.69 1.90 Sec61a1 KLA  ATP  ATP+KLA NM_016906 Sec61 alpha 1 subunit (S. cerevisiae) (Sec61a1), mRNA [NM_016906] KLA .97 .99 .99 1.04 1.05 1.07 1.21 ATP 1.03 1.02 .87 .94 .94 .96 1.23 KLA/ATP .98 .99 .90 .96 .77 .89 1.02 Sec61a2 KLA  ATP  ATP+KLA NM_021305 Sec61, alpha subunit 2 (S. cerevisiae) (Sec61a2), mRNA [NM_021305] KLA .86 .92 .91 .78 .84 .85 1.21 ATP 1.05 1.08 .72 .79 1.33 .93 1.13 KLA/ATP .91 .92 .68 .79 .88 1.03 1.02 Sec61b KLA  ATP  ATP+KLA NM_024171 Sec61 beta subunit (Sec61b), mRNA [NM_024171] KLA .95 .88 .80 .87 .74 .76 .93 ATP .93 .97 1.17 1.20 1.01 .84 .89 KLA/ATP .81 .89 1.04 .99 1.00 .82 .56 Sec61g KLA  ATP  ATP+KLA NM_011343 SEC61, gamma subunit (Sec61g), transcript variant 1, mRNA [NM_011343] KLA 1.19 1.06 1.12 1.34 1.13 1.11 1.10 ATP 1.09 .98 1.22 1.13 1.22 1.39 1.01 KLA/ATP 1.16 1.19 1.63 1.25 1.58 1.41 .96 Sftpa1 KLA  ATP  ATP+KLA NM_023134 surfactant associated protein A1 (Sftpa1), mRNA [NM_023134] KLA 1.00 1.05 1.03 1.07 1.00 1.01 .99 ATP 1.01 1.01 1.01 1.03 1.04 1.08 1.00 KLA/ATP 1.06 1.02 1.02 .99 1.04 1.02 1.04 Sftpd KLA  ATP  ATP+KLA NM_009160 surfactant associated protein D (Sftpd), mRNA [NM_009160] KLA 1.01 .96 1.01 .93 .98 1.02 .95 ATP .96 1.02 1.11 .97 .99 1.00 .94 KLA/ATP 1.04 1.02 1.00 .88 .98 .97 1.07 Stx12 KLA  ATP  ATP+KLA NM_133887 syntaxin 12 (Stx12), mRNA [NM_133887] KLA 1.29 1.33 1.32 1.44 1.49 1.40 1.14 ATP 1.01 1.04 1.05 .96 .87 1.33 1.42 KLA/ATP 1.27 1.29 1.24 1.32 1.09 1.42 1.50 Stx18 KLA  ATP  ATP+KLA NM_026959 syntaxin 18 (Stx18), mRNA [NM_026959] KLA 1.51 1.66 1.76 2.10 2.07 1.90 1.19 ATP 1.04 .99 1.22 1.32 .82 1.47 1.30 KLA/ATP 1.54 1.64 2.15 2.24 1.65 1.64 1.60 Stx7 KLA  ATP  ATP+KLA NM_016797 syntaxin 7 (Stx7), mRNA [NM_016797] KLA 1.16 1.06 1.31 1.15 1.38 1.31 1.11 ATP 1.15 1.02 .79 .72 .75 .70 1.15 KLA/ATP 1.15 1.10 .95 .84 .88 .76 1.10 Tap1 KLA  ATP  ATP+KLA NM_013683 transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) (Tap1), mRNA [NM_013683] KLA 7.60 7.62 9.05 9.01 9.36 8.57 4.96 ATP 1.00 1.07 .96 1.13 .74 2.83 2.43 KLA/ATP 7.99 8.80 8.37 9.52 7.44 8.61 9.95 Tap2 KLA  ATP  ATP+KLA NM_011530 transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) (Tap2), mRNA [NM_011530] KLA 4.36 4.80 4.71 5.53 4.94 5.09 2.85 ATP .93 1.12 .97 1.20 1.38 2.30 2.20 KLA/ATP 4.15 5.22 6.03 6.07 5.60 5.42 6.52 Tcirg1 KLA  ATP  ATP+KLA NM_016921 T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein A3 (Tcirg1), mRNA [NM_016921] KLA 1.32 1.42 1.49 1.38 1.94 2.26 1.98 ATP 1.01 1.16 .69 .96 1.24 1.32 2.03 KLA/ATP 1.50 1.58 .90 1.29 1.37 2.08 3.28 Tfrc KLA  ATP  ATP+KLA NM_011638 transferrin receptor (Tfrc), mRNA [NM_011638] KLA .77 .79 .86 .63 .45 .25 .31 ATP 1.07 1.11 1.09 .89 .75 .45 .17 KLA/ATP .89 .85 .77 .66 .40 .24 .09 Thbs1 KLA  ATP  ATP+KLA NM_011580 thrombospondin 1 (Thbs1), mRNA [NM_011580] KLA 2.22 2.22 2.74 3.10 4.57 7.17 7.22 ATP 1.16 2.53 8.45 12.26 15.50 43.06 35.83 KLA/ATP 2.46 3.43 8.29 17.50 28.16 46.17 54.67 Thbs2 KLA  ATP  ATP+KLA NM_011581 thrombospondin 2 (Thbs2), mRNA [NM_011581] KLA .99 1.03 1.04 1.03 1.04 1.17 1.03 ATP 1.01 1.04 1.01 1.02 .98 1.03 .97 KLA/ATP 1.08 1.04 .95 1.05 1.15 1.14 1.04 Thbs3 KLA  ATP  ATP+KLA NM_013691 thrombospondin 3 (Thbs3), mRNA [NM_013691] KLA .86 .93 .86 .95 .90 .79 .79 ATP 1.06 1.02 1.11 1.10 .96 1.03 1.07 KLA/ATP .90 .88 .92 .92 .98 .96 .98 Thbs4 KLA  ATP  ATP+KLA NM_011582 thrombospondin 4 (Thbs4), mRNA [NM_011582] KLA 1.16 1.13 1.19 1.13 1.13 1.16 1.07 ATP 1.00 1.14 1.07 .99 1.07 1.25 1.10 KLA/ATP 1.16 1.18 1.24 1.55 1.55 1.94 1.48 Tlr2 KLA  ATP  ATP+KLA NM_011905 toll-like receptor 2 (Tlr2), mRNA [NM_011905] KLA 13.65 11.82 8.87 7.95 4.67 2.78 2.33 ATP 1.06 1.24 2.76 6.28 11.55 13.82 .67 KLA/ATP 13.11 12.91 14.48 13.84 14.18 11.14 2.78 Tlr4 KLA  ATP  ATP+KLA NM_021297 toll-like receptor 4 (Tlr4), mRNA [NM_021297] KLA .69 .61 .75 .94 .64 .81 .73 ATP .95 .90 1.12 .56 .47 1.51 1.53 KLA/ATP .57 .62 1.01 .64 .39 .73 1.13 Tlr6 KLA  ATP  ATP+KLA NM_011604 toll-like receptor 6 (Tlr6), mRNA [NM_011604] KLA 6.41 6.63 6.53 6.69 4.70 4.27 2.63 ATP 1.04 .95 1.02 .65 1.11 5.02 3.78 KLA/ATP 6.27 6.99 7.49 5.08 4.10 4.69 7.46 Tuba1a KLA  ATP  ATP+KLA NM_011653 tubulin, alpha 1A (Tuba1a), mRNA [NM_011653] KLA .47 .44 .41 .41 .42 .35 .53 ATP 1.01 .94 1.07 .93 .53 .70 .60 KLA/ATP .45 .40 .44 .38 .48 .55 .49 Tuba1c KLA  ATP  ATP+KLA NM_009448 tubulin, alpha 1C (Tuba1c), mRNA [NM_009448] KLA .52 .54 .48 .42 .48 .71 .86 ATP .95 .96 .96 1.01 1.00 .92 .68 KLA/ATP .56 .48 .45 .49 .49 .70 .59 Tuba3a KLA  ATP  ATP+KLA NM_009446 tubulin, alpha 3A (Tuba3a), mRNA [NM_009446] KLA .80 .74 .76 .74 .76 .82 .89 ATP 1.05 1.10 .89 1.18 1.06 .93 .82 KLA/ATP .77 .74 .78 .82 .74 .82 .78 Tuba4a KLA  ATP  ATP+KLA NM_009447 tubulin, alpha 4A (Tuba4a), mRNA [NM_009447] KLA .54 .53 .48 .41 .42 .48 .94 ATP 1.00 1.11 .94 1.27 2.28 2.35 1.12 KLA/ATP .55 .53 .48 .64 1.25 1.79 1.11 Tuba8 KLA  ATP  ATP+KLA NM_017379 tubulin, alpha 8 (Tuba8), mRNA [NM_017379] KLA 1.01 1.13 1.19 1.11 1.11 1.20 .98 ATP .92 .99 1.09 1.02 1.01 .96 1.24 KLA/ATP 1.13 1.06 .97 1.13 1.05 1.07 1.11 Tubb2a KLA  ATP  ATP+KLA NM_009450 tubulin, beta 2a (Tubb2a), mRNA [NM_009450] KLA .48 .49 .49 .49 .65 .96 1.04 ATP .95 .98 .88 .91 1.09 1.09 .71 KLA/ATP .52 .50 .46 .53 .89 1.05 .65 Tubb2b KLA  ATP  ATP+KLA NM_023716 tubulin, beta 2b (Tubb2b), mRNA [NM_023716] KLA .67 .70 .68 .78 .57 .55 .53 ATP .91 1.02 1.40 1.30 2.56 3.08 .44 KLA/ATP .73 .84 1.13 .98 2.03 2.04 .36 Tubb2c KLA  ATP  ATP+KLA NM_146116 tubulin, beta 2c (Tubb2c), mRNA [NM_146116] KLA .43 .42 .43 .44 .64 .83 .98 ATP 1.00 1.07 .97 1.24 1.13 1.44 .95 KLA/ATP .48 .44 .44 .75 .71 1.13 .94 Tubb3 KLA  ATP  ATP+KLA NM_023279 tubulin, beta 3 (Tubb3), mRNA [NM_023279] KLA 1.56 1.62 1.56 2.14 2.06 2.94 1.61 ATP 1.01 .95 1.36 1.32 1.31 .92 .93 KLA/ATP 1.52 1.66 2.61 2.01 2.11 1.50 1.19 Tubb4 KLA  ATP  ATP+KLA NM_009451 tubulin, beta 4 (Tubb4), mRNA [NM_009451] KLA .64 .68 .65 .57 .63 .74 .92 ATP 1.06 1.19 1.02 1.25 .99 .67 .50 KLA/ATP .72 .65 .56 .74 .66 .61 .36 Tubb5 KLA  ATP  ATP+KLA NM_011655 tubulin, beta 5 (Tubb5), mRNA [NM_011655] KLA .52 .52 .51 .45 .52 .71 .97 ATP .99 1.02 .91 .91 .72 .55 .48 KLA/ATP .56 .50 .47 .47 .50 .45 .29 Tubb6 KLA  ATP  ATP+KLA AK041002 adult male aorta and vein cDNA, RIKEN full-length enriched library, clone:A530059D09 product:unclassifiable, full insert sequence [AK041002] KLA .49 .45 .48 .50 .46 .48 .53 ATP .89 .86 .90 .64 .49 .46 .47 KLA/ATP .42 .42 .57 .55 .48 .39 .38 Tubb6 KLA  ATP  ATP+KLA NM_026473 tubulin, beta 6 (Tubb6), mRNA [NM_026473] KLA .87 .85 .83 1.01 1.16 1.44 .34 ATP .90 .91 1.04 1.07 1.78 2.19 1.13 KLA/ATP .83 .75 .90 1.06 1.72 2.38 .91 Vamp3 KLA  ATP  ATP+KLA NM_009498 vesicle-associated membrane protein 3 (Vamp3), mRNA [NM_009498] KLA 1.20 1.23 1.47 1.36 1.53 1.52 1.10 ATP 1.05 1.18 1.09 1.35 1.14 1.24 1.22 KLA/ATP 1.39 1.38 1.09 1.61 1.18 1.44 1.63